Sarafem
Sarafem is a selective serotonin reuptake inhibitor (SSRI) containing fluoxetine hydrochloride. It is specifically indicated and marketed for the treatment of Premenstrual Dysphoric Disorder (PMDD).
Dosage by Body Weight
The typical dose is 20 mg taken orally once daily. It can be taken continuously (every day) or intermittently (starting 14 days before the anticipated onset of menstruation through the first full day of menses). Doses should be individualized under the direction of a healthcare provider.
- Body Weight
- Below 5 kg
- Dose
- Not indicated
- Frequency
- Do not use
- Tracking Notes
- Sarafem is intended for treating PMDD in menstruating individuals and is not appropriate for infants or young children.
- Body Weight
- 5-7 kg
- Dose
- Not indicated
- Frequency
- Do not use
- Tracking Notes
- Sarafem is intended for treating PMDD in menstruating individuals and is not appropriate for infants or young children.
- Body Weight
- 8-10 kg
- Dose
- Not indicated
- Frequency
- Do not use
- Tracking Notes
- Sarafem is intended for treating PMDD in menstruating individuals and is not appropriate for young children.
- Body Weight
- 11-15 kg
- Dose
- Not indicated
- Frequency
- Do not use
- Tracking Notes
- Sarafem is intended for treating PMDD in menstruating individuals and is not appropriate for young children.
- Body Weight
- 16-20 kg
- Dose
- Not indicated
- Frequency
- Do not use
- Tracking Notes
- Sarafem is intended for treating PMDD in menstruating individuals and is not indicated for children in this weight range.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not indicated | Do not use | Sarafem is intended for treating PMDD in menstruating individuals and is not appropriate for infants or young children. |
| 5-7 kg | Not indicated | Do not use | Sarafem is intended for treating PMDD in menstruating individuals and is not appropriate for infants or young children. |
| 8-10 kg | Not indicated | Do not use | Sarafem is intended for treating PMDD in menstruating individuals and is not appropriate for young children. |
| 11-15 kg | Not indicated | Do not use | Sarafem is intended for treating PMDD in menstruating individuals and is not appropriate for young children. |
| 16-20 kg | Not indicated | Do not use | Sarafem is intended for treating PMDD in menstruating individuals and is not indicated for children in this weight range. |
Formulation
Purpose
Treatment of Premenstrual Dysphoric Disorder (PMDD) to reduce emotional and physical symptoms such as mood swings, irritability, bloating, and breast tenderness.
Generic Name
Fluoxetine hydrochlorideScheduled Drug
No. This medicine is generally not treated as a scheduled/prescription-only drug in common consumer references, but local rules may vary.